Autor: Arnab De

Arnab De, M.A, M.Phil , is currently a Ph D candidate at Columbia University Medical Center. He completed his undergraduate education in Presidency College, Calcutta, India before coming to the Unites States for his higher education. He came to Indiana University, Bloomington where he worked with Prof. Richard Di Marchi (Standiford H. Cox Professor of Chemistry and the Linda & Jack Gill Chair in Biomolecular Sciences) to develop peptide-based prodrugs as therapeutics for diabetes. The work with Prof. Di Marchi resulted in two patents (licensed by Marcadia Biotech, recently acquired by Roche) and multiple publications in peer reviewed journals. He presented his findings in the American Peptide Symposium’2009 and received the Young Investigator’s Award. He subsequently came to Columbia University where he is developing transgenic mice to serve as potential models for autoimmune diseases. He was invited by Carolyn J Honour (Editorial Director, Biomedicine at Springer) to write this bookin the Springer Brief series. The foreword has been written by Prof. Jean Martinez (Legion d”Honneur awarded by the French Republic and Chairman of European Peptide Society, 2002-2010).